Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex
Science Immunology · 31.03.2023 · 8 (81)
DOI: 10.1126/sciimmunol.adc9324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 31.03.2023. Verfasst von Taiichiro Shirai und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune Response Dynamics, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Immunity, Humoral, Autoimmune Diseases. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Celastrol, a bioactive molecule extracted from the Tripterygium wilfordii plant, has been shown to exhibit anti-inflammatory properties. However, its mechanism of action has not been fully elucidated. Here, we show that celastrol suppresses humoral immune responses and autoimmunity by disabling a protein complex consisting of copper metabolism MURR1 domain–containing (COMMD) 3 and COMMD8 (COMMD3/8 complex), a signaling adaptor for chemoattractant receptors. Having demonstrated the involvement of the COMMD3/8 complex in a mouse model of rheumatoid arthritis, we identified celastrol as a compound that covalently bound to and dissociated the COMMD3/8 complex. Celastrol inhibited B cell migration, reduced antibody responses, and blocked arthritis progression, recapitulating deficiency of the COMMD3/8 complex. These effects of celastrol were abolished in mice expressing a celastrol-resistant mutant of the COMMD3/8 complex. These findings establish that celastrol exerts immunosuppressive activity by targeting the COMMD3/8 complex. Our study suggests that the COMMD3/8 complex is a potentially druggable target in autoimmune diseases and points to celastrol as a lead pharmacologic candidate in this capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Immune Response Dynamics, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
- Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
- Department of Immune Response Dynamics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
- Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
- Laboratory for Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.
- Thermo Fisher Scientific K.K., Yokohama, Kanagawa, Japan.
ORCID-Profile: Taiichiro Shirai, Akiko Nakai, Emiko Ando, Jun Fujimoto, Sarah Leach, Takao Arimori, Daisuke Higo, Floris J van Eerden, Janyerkye Tulyeu, Yu-Chen Liu, Daisuke Okuzaki, Haruhiko Miyata, Kazuto Nunomura, Bangzhong Lin, Akiyoshi Tani, Atsushi Kumanogoh, Masahito Ikawa, James B Wing, Daron M Standley, Junichi Takagi, Kazuhiro Suzuki
Zitieren
APA
Shirai, T., Nakai, A., Ando, E., Fujimoto, J., Leach, S., Arimori, T., Higo, D., van Eerden, F. J., Tulyeu, J., Liu, Y. C., Okuzaki, D., Murayama, M. A., Miyata, H., Nunomura, K., Lin, B., Tani, A., Kumanogoh, A., Ikawa, M., Wing, J. B., …, & Suzuki, K. (2023). Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex. Science Immunology, 8(81). https://doi.org/10.1126/sciimmunol.adc9324
Vancouver
Shirai T, Nakai A, Ando E, Fujimoto J, Leach S, Arimori T, et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex. Science Immunology. 2023;8(81). doi:10.1126/sciimmunol.adc9324
BibTeX
@article{Shirai2023,
author = {Shirai, Taiichiro and Nakai, Akiko and Ando, Emiko and Fujimoto, Jun and Leach, Sarah and Arimori, Takao and Higo, Daisuke and van Eerden, Floris J and Tulyeu, Janyerkye and Liu, Yu-Chen and Okuzaki, Daisuke and Murayama, Masanori A and Miyata, Haruhiko and Nunomura, Kazuto and Lin, Bangzhong and Tani, Akiyoshi and Kumanogoh, Atsushi and Ikawa, Masahito and Wing, James B and Standley, Daron M and Takagi, Junichi and Suzuki, Kazuhiro},
title = {Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {81},
doi = {10.1126/sciimmunol.adc9324}
}
EUVIMED